Haemonetics Corp
HAE· NYSE
Filed Aug 11, 2010 · 10-Q · 39 days after period end · 0000950123-10-076132
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenue | $163.04M | $154.09M |
| Net Income | $17.92M | $18.07M |
| EPS Diluted | $0.70 | $0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
ended Jul 3, 2010 · filed Aug 11, 2010 · 39 d after period end